Defining the Role of SGLT2 Inhibitors in Primary Care: Time to Think Differently - PubMed

https://pubmed.ncbi.nlm.nih.gov/35349120/

La biblioteca de Springfield: Glifozinas en diabetes mellitus

https://rubenroa.blogspot.com/2019/12/glifozinas-en-diabetes-mellitus.html


Enviado desde mi iPhone

¿De verdad el NPS es la mejor medida de la experiencia del paciente? En favor de los PREM Carlos Bezos Daleske

https://www.newmedicaleconomics.es/wp-content/uploads/2022/03/experiencia-del-paciente.pdf

From the Eyeball Test to the Algorithm — Quality of Life, Disability Status, and Clinical Decision Making in Surgery | NEJM

https://www.nejm.org/doi/full/10.1056/NEJMms2207408


Enviado desde mi iPhone

Diabetes Management in Chronic Kidney Disease: A Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO) | Diabetes Care | American Diabetes Association

https://diabetesjournals.org/care/article/doi/10.2337/dci22-0027/147614/Diabetes-Management-in-Chronic-Kidney-Disease-A


Enviado desde mi iPhone

https://nej.md/3BE8y7y

https://nej.md/3BE8y7y


Enviado desde mi iPhone

ThinkCascades: A Tool for Identifying Clinically Important Prescribing Cascades Affecting Older People | SpringerLink

https://link.springer.com/article/10.1007/s40266-022-00964-9


Enviado desde mi iPhone